IMCD N.V.

Last price update: 04 Oct 24 18:35 GMT

Price:
EUR152.00
Open:
EUR152.90
Previous close:
EUR153.25
Day's range:
EUR152.00 - EUR154.20
Year's range:
EUR109.05 - EUR169.05
Net Income per Share:
4.92
Price-to-Earnings ratio:
30.89
52-week Price Range:
EUR146.23
Volume:
EUR70,493.00
Average volume:
EUR88,525.00

Company profile for IMCD N.V.

IMCD N.V. logo

IMCD N.V. distributes, markets, and sells specialty chemicals and ingredients in the Netherlands, rest of Europe, the Middle East, Africa, North America, South America, and the Asia-Pacific. The company offers enzymes, surfactants, biocides, chelates, rheology modifiers, solubilisers, silicones, solvents, and functional additives; active pharmaceutical, agrochemicals, biopharma, excipients and formulation, nutraceuticals, and regulated synthesis; actives, UV sunscreens, rheology modifiers, thickeners, emulsifiers, emollients, elastomers, humectants, waxes, film formers, functional powders, hair styling polymers, hair conditioners, solvents, solubilizers, pigments, pearls, colorants, opacifiers, pearlisers, preservatives, antioxidants, additives, fragrances, and essential oils; and resins and binders, additives, functional fillers, and specialty solvents. It also provides taste, texture, nutrition, and function; base oil, fuel addictive, lubricants addictive, lubricants finished fluids, solvents, degreasers and fuel, compounds, and upstream, midstream and downstream oil, gas and energy; bio-based chemicals, catalysts, intermediates, monomers, organic building blocks, processing aids, reactive diluents, solvents, and surfactants. IMCD N.V. was founded in 1995 and is headquartered in Rotterdam, the Netherlands.

Stock exchanges:
AMS
Sector:
Basic Materials
Industries:
Specialty Chemicals
Ticker:
IMCD.AS
ISIN:
NL0010801007
Website:
https://www.imcdgroup.com
Phone:
31 10 290 8684
Origin:
Netherlands
Employees:
4,013

IMCD N.V. Press Releases

Imcd raises eur 400 mln through accelerated bookbuild offering of new shares

Imcd successfully raises eur 400 million through an accelerated bookbuild offering of new shares. newly issued shares represent 8.4% of imcd' s issued share capital before capital increase and 7.7% after transaction. net proceeds of offering will be used by company for general corporate purposes and to finance acquisition of 70% of signet excipients private limited (" signet"). after settlement total number of issued ordinary shares of imcd will amount to 56,987,85. new shares will rank pari passu in all respects with outstanding ordinary shares of company, including any rights to dividends.

Imcd launches accelerated bookbuild offering of new shares, buys signet

Reg imcd announces the launch of an accelerated bookbuild offering of new shares. offering will be executed by way of an accelerated bookbuild offering of new shares. bookbuilding procedure will commence with immediate effect following release of this announcement. offering will consist of up to approximately eur 400 million worth of ordinary shares. intends to use net proceeds of offering for general corporate purposes and to finance acquisition of signet excipients private limited.

Imcd expands distribution partnership with imerys performance minerals

Imerys performance minerals expands distribution partnership with imcd throughout u. s. and canada. imcd will now represent imerys performance minerals as its preferred distributor across the u. s. and canada. imcd will represent nearly all imerys mineral offerings, with the exception of air float kaolin in canada.

Imcd signs agreement to buy south african distributor siyeza

Imcd’ s growth story solidifies with the envisaged acquisition of siyeza in south africa. has successfully signed an agreement to acquire 100% of shares in south african distributor siyeza fine chem propriety limited (" siyeza"). closing of transaction is subject to customary regulatory review and is expected in DEC ember 2020. company will continue with its present management and staff.

Imcd buys vitaqualy comércio de ingredientes

Imcd bolsters brazil speciality distribution strategy by acquiring vitaqualy comércio de ingredientes. announced it has acquired 100% of outstanding shares of brazilian speciality ingredient distributor, vitaqualy comércio de ingredientes ltda (" vitaqualy"). company will be fully integrated into imcd’ s organisation in 2021. SYN ergies between imcd and vitaqualy will create opportunities to develop offering to suppliers and customers.

Imcd h1 operating ebita up at eur 131.4 million

Imcd reports 7% ebita growth in the first half of 2020. in the first half of 2020, free cash flow was eur 76.3 million compared to eur 80.9 million in the first half of 2019 ( 6%). as at 30 june 2020, net debt was eur 767.9 million compared to eur 735.2 million as at 31 DEC ember 2019. uncertainty around the duration of the covid 19 crisis and its impact on the global economy makes it impossible to give a near term trading outlook. h1 revenue increased from eur 1,398.1 million to eur 1,411.2 million, an increase of 1% compared to the first half of 2019. h1 cash earnings per share increased by 5% to eur 1.69 ( first half of 2019 eur 1.60). h1 net result before amortisation and non recurring items increase of 6% to eur 90.2 mln ( 7% on a constant currency basis). h1 operating ebita increase of 7% to eur 131.4 mln ( 8% on a constant currency basis).